華雅旗下紅榮微再授權代理（上海）TAKARA CellArtis，Rubicon產品 現貨數量有限 詳詢 手機：1500 1904 520 紅榮微再-客服: 經銷商專員：
Cellartis定型內胚層干細胞
產品英文名稱：Cellartis Definitive Endoderm Cells (from ChiPSC18)
產品中文名稱：Cellartis定型內胚層干細胞
適合用于進一步誘導分化成為肝臟細胞類型或是胰臟細胞類型。
Cellartis定型內胚層干細胞（DE cell）是從hiPS細胞株ChiPSC18經體外誘導分化得來。該產品中，大于90%的細胞顯示表達SOX17蛋白。該產品為低溫冷凍保存的細胞懸浮形式。本產品適合用于進一步誘導分化成為肝臟細胞類型或是胰臟細胞類型。特別地，Cellartis的肝臟細胞誘導分化試劑盒（Cellartis Hepatocyte Differentiation Kit，Cat. No. Y30050）適合用于DE向肝臟細胞類型的誘導分化工作。
在產生Cellartis定型內胚層細胞（來自ChiPSC18）的分化過程中，通過RT-qPCR測量的mRNA表達譜顯示內胚層標志物SOX17，FOXA2，FZD5，CXCR4，HHEX和SOX7的預期時間表達; 中胚層標記Brachyury; 和多能標記OCT4。
Cellartis Definitive Endoderm Cells (from ChiPSC18) are human definitive endoderm (DE) cells derived from the human induced pluripotent stem (hiPS) cell line ChiPSC18. The hiPS cells have been differentiated into definitive endoderm cells in vitro to generate a population of >90% SOX17-protein-expressing cells; they are then dissociated into a cell suspension and cryopreserved. These DE cells are suitable for further differentiation into hepatocytes or pancreatic endoderm cells. To differentiate the DE cells into hepatocytes, use the Cellartis Hepatocyte Differentiation Kit (Cat. No. Y30050).
During the differentiation process that creates Cellartis Definitive Endoderm Cells (from ChiPSC18), the mRNA expression profile—as measured by RT-qPCR—shows the expected temporal expression of endodermal markers SOX17, FOXA2, FZD5, CXCR4, HHEX, and SOX7; mesoendodermal marker Brachyury; and pluripotency marker OCT4. See the Images & Data tab, below.
產品特點:
具有> 90％SOX17陽性細胞的定形內胚層細胞
可用于下一步分化內胚層起源的下級分化細胞，如肝細胞或胰腺內胚層
Definitive endoderm cells with >90% SOX17-positive cells
Can be used for generating further-specified cells of endodermal origin, such as hepatocytes or pancreatic endoderm
組份：
Cellartis Definitive Endoderm Cells (from ChiPSC18) (Cat. No. Y10040)
保存：Cellartis Definitive Endoderm Cells (from ChiPSC18) should be stored at ≤ –150°C. Under
recommended storage conditions, the cells can be stored for up to one year from the date of receipt.
Culture thawed Cellartis Definitive Endoderm Cells (from ChiPSC18) at 37°C ± 1°C, 5% CO2 and>90% humidity.
產品性能：
Immunocytochemistry of Cellartis Definitive Endoderm Cells (from ChiPSC18). Cells were thawed, cultured for two days, fixed, and stained for the pluripotency marker OCT4, the definitive endoderm marker SOX17, and the nuclear marker DAPI. Results show that more than 90% of the cell population are definitive endoderm cells and have lost pluripotency.
相關產品：
Cellartis DEF-CS™ 500 COAT-1 (Takara Bio, Cat. No. Y30012)
iMatrix-511 (Takara Bio, Cat. No. T303)
iMatrix-511 (Takara Bio, Cat. No. T304)
Cellartis Hepatocyte Differentiation Kit (Takara Bio, Cat. No. Y30050)
肝細胞培養完整解決方案
人iPS誘導分化成肝細胞全過程的完整試劑盒：Y30055（新產品）
人iPS來源肝細胞株及*培養基Y10133/Y10134/Y10135（新產品）
人原代肝臟細胞培養基 Y20020（新產品）
http://www.chem17.com/st321032/article_1496885.html
華雅再生醫學旗艦公司：紅榮微再（上海）生物工程技術有限公司主營細胞治療和精準醫療等產品，2018年與TAKARA繼續合作，授權代理（上海）其旗下Cellartis干細胞研究制品和Rubicon單細胞文庫構建試劑。Cellartis公司位于瑞典，擁有iPS細胞等干細胞分化為肝細胞及臟器細胞的分化誘導技術和ES細胞，ips細胞，分化細胞等干細胞相關產品。
Cellartis-Y10040 Human Stem Cell Derived Definitive Endoderm Cells 及更多細胞培養基產品咨詢電話 手機1500 1904 520 紅榮微再-客服： 經銷商專員：
